Replay available

Rain Enhancement Technologies Holdco, Inc. (RAIN) Q2 2023 Earnings Call

Rain Enhancement Technologies Holdco, Inc. (NASDAQ: RAIN) Q2 2023 earnings conference call, held 2023-08-10. Replay captured from the company's public earnings webcast.

Thu, August 10, 2023 at 5:00 PMendedReplay
Rain Enhancement Technologies Holdco, Inc. (RAIN) Q2 2023 Earnings Call

Hosted by

Featured presenters

Dan Barry

LifeSci Advisors

Avinash Valenki

Chief Executive Officer, Reign Oncology, Inc.

Nelson Tabatouan

Acting Senior Vice President of Finance, Reign Oncology, Inc.

Michael Schmidt

Analyst, Guggenheim Securities

Ashk Mubarak

Analyst, FECOL

Joe Catanzaro

Analyst, Piper Sandler

Greg Savannah

Analyst, MISU Securities

Dr. Robert Doble

Chief Scientific Officer and Chief Medical Officer, Reign Oncology, Inc.

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Rain Enhancement Technologies Holdco, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:03.771 Good afternoon, ladies and gentlemen, and welcome to the Reign Oncology, Inc. 00:00:03.771 -- 00:00:07.934 Second Quarter 2023 Earnings Conference Call. 00:00:07.934 -- 00:00:12.617 At this time, all lines are in listen-only mode, and following the presentation, we will 00:00:12.617 -- 00:00:14.078 conduct 00:00:14.078 -- 00:00:18.761 a question-and-answer session. If at any time during the call you require immediate assistance, 00:00:18.761 -- 00:00:23.534 please press star zero for the operator. This call is being recorded on Thursday, August 00:00:23.534 -- 00:00:28.207 10, 2023. I would now like to turn the conference call over to Mr. 00:00:28.207 -- 00:00:33.472 Dan Barry of LifeSci Advisors, please go ahead. 00:00:33.813 -- 00:00:36.855 Thank you, Operator, and good afternoon, everyone. 00:00:36.855 -- 00:00:41.877 With me today on the phone is Avinash Valenki, Chief Executive Officer of Raid Oncology, 00:00:41.877 -- 00:00:45.799 and Nelson Cabochon, Acting SVP of Finance. 00:00:45.799 -- 00:00:50.201 Following the call, Dr. Robert Doble, Chief Scientific Officer and Chief Medical Officer, 00:00:50.201 -- 00:00:54.102 will be joining Avinash and Nelson for a short Q&A. 00:00:54.251 -- 00:00:57.832 Earlier today, RAINN issued a news release announcing the company's results for the second 00:00:57.832 -- 00:01:00.102 quarter of 2023. 00:01:00.113 -- 00:01:03.914 Copies of this news release and SEC filings can be found in the Investors section of 00:01:03.914 -- 00:01:05.514 our website. 00:01:05.514 -- 00:01:10.716 Full details on updates from the quarter can be found in our news release and 10-Q issued 00:01:10.716 -- 00:01:12.376 today. 00:01:12.376 -- 00:01:15.637 Before we begin, I would like to remind you that statements ...